Cargando…

Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation

BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelghani, Mohammad, Cavalcante, Rafael, Miyazaki, Yosuke, de Winter, Robbert J., Sarmento-Leite, Rogério, Mangione, José A., Abizaid, Alexandre, Lemos, Pedro A., Serruys, Patrick W., de Brito, Fabio S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565654/
https://www.ncbi.nlm.nih.gov/pubmed/28444455
http://dx.doi.org/10.1007/s00392-017-1119-9
_version_ 1783258424053596160
author Abdelghani, Mohammad
Cavalcante, Rafael
Miyazaki, Yosuke
de Winter, Robbert J.
Sarmento-Leite, Rogério
Mangione, José A.
Abizaid, Alexandre
Lemos, Pedro A.
Serruys, Patrick W.
de Brito, Fabio S.
author_facet Abdelghani, Mohammad
Cavalcante, Rafael
Miyazaki, Yosuke
de Winter, Robbert J.
Sarmento-Leite, Rogério
Mangione, José A.
Abizaid, Alexandre
Lemos, Pedro A.
Serruys, Patrick W.
de Brito, Fabio S.
author_sort Abdelghani, Mohammad
collection PubMed
description BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI. METHODS AND RESULTS: Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p < 0.001 and 2.16 (95% CI: 1.08–4.35), p = 0.030, respectively]. Even mild residual functional impairment (NYHA II) was associated with a higher all-cause [HR: 2.02 (95% CI: 1.10–3.72), p = 0.023] and cardiac [HR: 2.08 (95% CI: 1.42–3.07), p < 0.001] mortality. CONCLUSION: Residual impairment of functional capacity is common after TAVI and is independently associated with increased mortality. Predictors of residual impairment of functional status are predominantly patient-rather than procedure-related. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-017-1119-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5565654
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-55656542017-09-06 Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation Abdelghani, Mohammad Cavalcante, Rafael Miyazaki, Yosuke de Winter, Robbert J. Sarmento-Leite, Rogério Mangione, José A. Abizaid, Alexandre Lemos, Pedro A. Serruys, Patrick W. de Brito, Fabio S. Clin Res Cardiol Original Paper BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI. METHODS AND RESULTS: Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p < 0.001 and 2.16 (95% CI: 1.08–4.35), p = 0.030, respectively]. Even mild residual functional impairment (NYHA II) was associated with a higher all-cause [HR: 2.02 (95% CI: 1.10–3.72), p = 0.023] and cardiac [HR: 2.08 (95% CI: 1.42–3.07), p < 0.001] mortality. CONCLUSION: Residual impairment of functional capacity is common after TAVI and is independently associated with increased mortality. Predictors of residual impairment of functional status are predominantly patient-rather than procedure-related. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-017-1119-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-04-25 2017 /pmc/articles/PMC5565654/ /pubmed/28444455 http://dx.doi.org/10.1007/s00392-017-1119-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Abdelghani, Mohammad
Cavalcante, Rafael
Miyazaki, Yosuke
de Winter, Robbert J.
Sarmento-Leite, Rogério
Mangione, José A.
Abizaid, Alexandre
Lemos, Pedro A.
Serruys, Patrick W.
de Brito, Fabio S.
Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title_full Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title_fullStr Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title_full_unstemmed Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title_short Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
title_sort prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565654/
https://www.ncbi.nlm.nih.gov/pubmed/28444455
http://dx.doi.org/10.1007/s00392-017-1119-9
work_keys_str_mv AT abdelghanimohammad prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT cavalcanterafael prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT miyazakiyosuke prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT dewinterrobbertj prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT sarmentoleiterogerio prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT mangionejosea prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT abizaidalexandre prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT lemospedroa prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT serruyspatrickw prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation
AT debritofabios prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation